Dr. Jochen Lennerz, MD

• Molecular Genetic Pathology

• Anatomic Pathology

*Healthgrades does not verify qualifications for medical specialties. Please verify your provider's specialty and qualifications directly with your provider and applicable medical board.

• Washington University In St L

  Fellowship Hospital

• Washington University, St Louis

  Residency Hospital

• University Erlangen-nuremberg

  Medical School, 2003

• Spectrum of Mechanisms of Resistance to Crizotinib and Lorlatinib inROS1Fusion-Positive Lung Cancer, 2021-03-08

• The landscape of metastatic progression patterns across major human cancers, 2014-11-04

• Diagnostic Value of MAML2 Rearrangements in Mucoepidermoid Carcinoma, 2022-04-13

• Sustainable development goals applied to digital pathology and artificial intelligence applications in low- to middle-income countries, 2023-05-15

• Prognostic role of inflammatory diets in colorectal cancer overall and in strata of tumor-infiltrating lymphocyte levels, 2022-11-27

• ROS1fusions rarely overlap with other oncogenic drivers in non-small cell lung cancer, 2017-01-11

• BRAF V600E Mutations Are Common in Pleomorphic Xanthoastrocytoma: Diagnostic and Therapeutic Implications, 2011-03-29

• Integrative molecular characterization of resistance to neoadjuvant chemoradiation in rectal cancer, 2019-06-28

• Clinicopathologic and Imaging Features of Non-Small-Cell Lung Cancer withMETExon 14 Skipping Mutations, 2019-12-17

• Suppressor of cytokine signaling 1gene mutation status as a prognostic biomarker in classical Hodgkin lymphoma, 2015-08-20

• Brigatinib in Patients with Alectinib-RefractoryALK-Positive Non-Small Cell Lung Cancer: A Retrospective Study, 2018-06-20

• A Phase II Study of Capmatinib in Patients with MET-Altered Lung Cancer Previously Treated with a MET Inhibitor, 2021-02-03

• Lymph node metastases develop through a wider evolutionary bottleneck than distant metastases, 2020-05-25

• Bridging the Gap: The Critical Role of Regulatory Affairs and Clinical Affairs in the Total Product Life Cycle of Pathology Imaging Devices and Software, 2021-11-17

• Association ofFusobacterium nucleatumwith Specific T Cell Subsets in the Colorectal Carcinoma Microenvironment, 2021-02-25

• MET Alterations are a Recurring and Actionable Resistance Mechanism in ALK-Positive Lung Cancer, 2020-02-21

• Human and mouse trigeminal ganglia cell atlas implicates multiple cell types in migraine, 2022-03-28

• Polyclonal secondary FGFR2 mutations drive acquired resistance to FGFR inhibition in patients with FGFR2 fusion-positive cholangiocarcinoma, 2016-12-29

• Sequential ALK Inhibitors Can Select for Lorlatinib-Resistant CompoundALKMutations in ALK-Positive Lung Cancer, 2018-04-12

• COVID-19 neutralizing antibodies predict disease severity and survival, 2020-12-15

• Molecular heterogeneity and receptor co-amplification drive resistance to targeted therapy inMET-amplified esophagogastric cancer, 2015-10-02

• Treatment with Next-Generation ALK Inhibitors Fuels PlasmaALKMutation Diversity, 2019-07-29

• A unifying force for the realization of medical AI, 2022-11-15

• Serial ctDNA monitoring to predict response to systemic therapy in metastatic gastrointestinal cancers, 2020-01-15

• Highdicom: a Python Library for Standardized Encoding of Image Annotations and Machine Learning Model Outputs in Pathology and Radiology, 2022-08-22

• TAS-120 overcomes resistance to ATP-competitive FGFR inhibitors in patients with FGFR2 fusion-positive intrahepatic cholangiocarcinoma, 2019-05-20

• Clinical and Imaging Features of Non-Small Cell Lung Cancer with G12C KRAS Mutation, 2021-07-16

• Recruited macrophages elicit atrial fibrillation, 2023-07-13

• Landscape of acquired resistance to osimertinib inEGFR-mutant NSCLC and clinical validation of combined EGFR and RET inhibition with osimertinib and BLU-667 for acquiredRETfusion., 2018-09-26

• Food Addiction, High Glycemic Index Carbohydrates and Obesity, 2017-11-20

• Clinicopathologic Features of Non-Small-Cell Lung Cancer Harboring anNTRKGene Fusion, 2018-07-23

• COVID-19 neutralizing antibodies predict disease severity and survival, 2020-10-20

• Developmental Deconvolution for Classification of Cancer Origin, 2022-11-02

• Immune cell profiles in the tumor microenvironment of early-onset, intermediate-onset, and later-onset colorectal cancer, 2021-09-16

• Test performance evaluation of SARS-CoV-2 serological assays, 2020-08-27

• Targeted ultra-deep sequencing reveals recurrent and mutually exclusive mutations of cancer genes in blastic plasmacytoid dendritic cell neoplasm, 2014-07-16

• Tracking the Evolution of Resistance to ALK Tyrosine Kinase Inhibitors through Longitudinal Analysis of Circulating Tumor DNA, 2018-01-23

• Clinical acquired resistance to KRASG12Cinhibition through a novel KRAS switch-II pocket mutation and polyclonal alterations converging on RAS-MAPK reactivation, 2021-04-06

• Amyloid precursor protein-fragments-containing inclusions in cardiomyocytes with basophilic degeneration and its association with cerebral amyloid angiopathy and myocardial fibrosis, 2018-11-09

• Bayesian risk prediction model for colorectal cancer mortality through integration of clinicopathologic and genomic data, 2023-06-10

• Smoking Status at Diagnosis and Colorectal Cancer Prognosis According to Tumor Lymphocytic Reaction, 2020-05-14

• Detecting predictive androgen receptor modifications in circulating prostate cancer cells, 2015-04-23

• Exploring the Skin Brain Link: Biomarkers in the Skin with Implications for Aging Research and Alzheimer's Disease Diagnostics, 2023-08-28

• Small cell transformation ofROS1fusion-positive lung cancer resistant to ROS1 inhibition, 2020-08-03

• Computational pathology in 2030: a Delphi study forecasting the role of AI in pathology within the next decade, 2023-01-04

• Development of oil-based gels as versatile drug delivery systems for pediatric applications, 2022-05-01

• Response to RET-Specific Therapy inRETFusion-Positive Anaplastic Thyroid Carcinoma RET Inhibitor Therapy inRETFusion ATC, 2020-09-08

• Report on computational assessment of Tumor Infiltrating Lymphocytes from the International Immuno-Oncology Biomarker Working Group, 2020-05-12

• Mucoepidermoid carcinoma (MEC) and adenosquamous carcinoma (ASC), the same or different entities?, 2022-07-23

• Molecular Analysis of Plasma from Patients withROS1-Positive Non-Small Cell Lung Cancer, 2019-01-18

• Pan-sarcoma genomic analysis ofKMT2Arearrangements reveals distinct subtypes defined byYAP1-KMT2A-YAP1andVIM-KMT2Afusions, 2020-05-27